NeOnc Technologies Holdings, Inc. (NTHI)
NASDAQ: NTHI · Real-Time Price · USD
5.53
+0.62 (12.63%)
At close: Aug 18, 2026, 4:00 PM EDT
5.47
-0.06 (-1.08%)
After-hours: Aug 18, 2026, 7:34 PM EDT
NeOnc Technologies Holdings Employees
NeOnc Technologies Holdings had 5 employees as of December 31, 2025. The number of employees decreased by 3 or -37.50% compared to the previous year.
Employees
5
Change
-3
Growth
-37.50%
Revenue / Employee
$7,998
Profits / Employee
-$9,440,000
Market Cap
137.46M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 5 | -3 | -37.50% |
| Dec 31, 2023 | 8 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| LENZ Therapeutics | 152 |
| Vivani Medical | 42 |
| Milestone Pharmaceuticals | 38 |
| Aardvark Therapeutics | 28 |
| Jyong Biotech | 27 |
| TuHURA Biosciences | 22 |
| Outlook Therapeutics | 17 |
| Equillium | 15 |
NTHI News
- 10 hours ago - NeOnc Technologies- Talk Is Cheap, Insider Buying Isn't - GlobeNewsWire
- 1 day ago - These Nasdaq Stories Are Heating Up - GlobeNewsWire
- 1 day ago - NTHI's Nasdaq Advantage Takes on New Meaning After Its Breakthrough Phase 2a Results - GlobeNewsWire
- 1 day ago - NeOnc says Phase 2a portion of NEO100-01 study met primary endpoint - TheFly
- 4 days ago - NeOnc Technologies Holdings Transcript: AGM 2026 - Transcripts
- 5 days ago - Stonegate Capital Partners Updates Coverage on NeOnc Technologies Holdings, Inc. (NTHI) 2Q26 - Newsfile Corp
- 5 days ago - The Nose Knows: Why NeOnc's Patent Portfolio Could Make NTHI More Than a One-Drug Biotech - GlobeNewsWire
- 6 days ago - Targeting The Mutant: NTHI's NEO100 Data Could Open a New Front in the Fight Against Brain Cancer - GlobeNewsWire